NeuroscienceBritish Journal of PharmacologyPeer-reviewed
ApTOLL, a new therapeutic aptamer for cytoprotection and (re)myelination after Multiple Sclerosis.
Beatriz Fernández‐Gómez, Miguel Marchena, David Piñeiro…·Fernando de Castro
ApTOLL, an aptamer targeting TLR4, shows immunomodulatory and remyelinating effects in MS models and cell cultures.